Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Infinityon May 03, 2024 12:02pm
153 Views
Post# 36021824

RE:RE:RE:RE:News Out

RE:RE:RE:RE:News OutOne would think that the TLT Management would have known about this agonizingly slow processing time for BTD Applications when they made the forecast that BTD a possibility in 1st quarter 2024.  As far as I know, TLT has not even completed the Pre- BTD and obtained guidance to go ahaed with the formal  BTD application.  We all know TLT obtained Fast Track status before COVID hit us.  I think frequent changes in Management is the main reason for the lack of continuity.  Dr. Shirazi was doing fine for a few years, folliwed by Dr. Vera Madzarvic, few more on the Device side of the business as well.  Leads me to believe RDW either has a real problem in holding on to skilled and talented people that he hired in the first place or he tends to hire the wrong people for senior positions.  Either case it is time to get his act back on track.  Hope for something positive very soon..
<< Previous
Bullboard Posts
Next >>